Gloros

Gloros is an oral iron supplement that contains the active ingredient ferrous gluconate. It is marketed in the European Union as an over‑the‑counter product. The specific strength and dosage form are not disclosed, but the formulation is intended to provide elemental iron for individuals with iron deficiency or at risk of deficiency. Gloros is classified as an iron deficiency anemia supplement (ATC code B03AA07) commonly.

Gloros is indicated for the management and prevention of iron deficiency related conditions.

- Treatment of iron deficiency anemia in adults. - Prevention of iron deficiency in individuals with increased physiological demand, such as during pregnancy or growth periods. - Support for patients with chronic blood loss, for example due to gastrointestinal bleeding. - Adjunct therapy for individuals following bariatric surgery or other conditions that impair iron absorption. - Use in dietary supplementation when dietary iron intake is insufficient.

Oral ferrous gluconate may be associated with a range of gastrointestinal and systemic effects.

Common: - Nausea or upset stomach. - Constipation or loose stools. - Abdominal discomfort or cramping. - Darkened stools (harmless discoloration). - Metallic taste in the mouth.

Serious: - Severe allergic reaction (e.g., rash, swelling, difficulty breathing). - Persistent vomiting or severe abdominal pain. - Black, tar‑like stools indicating possible gastrointestinal bleeding. - Signs of iron overload such as fatigue, joint pain, or organ dysfunction. - Sudden drop in blood pressure (hypotension).

Before using Gloros, consider the following safety points.

- Do not use if you have a known hypersensitivity to ferrous gluconate or any excipients. - Avoid in conditions of iron overload, such as hereditary hemochromatosis. - Monitor iron status regularly during prolonged therapy. - Keep the product out of reach of children to prevent accidental overdose. - Use caution when taking antacids, calcium supplements, or foods high in phytates, as they may reduce absorption. - Consult a healthcare professional before use during pregnancy, lactation, or in patients with chronic kidney disease.

Ferrous gluconate can affect the absorption or effectiveness of several other agents.

Avoid: - Tetracycline and quinolone antibiotics (reduced antibiotic absorption). - Levothyroxine (thyroid hormone replacement). - Bisphosphonates used for osteoporosis. - Antacids containing aluminum, magnesium, or calcium. - Certain mineral supplements (e.g., zinc, copper) taken simultaneously.

Use with caution: - Vitamin C or ascorbic acid (may increase iron absorption, potentially leading to excess). - Calcium supplements (may modestly reduce iron uptake). - Proton pump inhibitors or H2 blockers (alter gastric acidity, affecting absorption). - Foods rich in phytates or polyphenols (e.g., tea, coffee, whole grains) when taken close to the dose. - Herbal products such as St. John’s wort, which can affect drug metabolism.